COCP Stock Analysis: Buy, Sell, or Hold?
COCP - Cocrystal Pharma, Inc. Common Stock
$1.44
0.05 (3.60%)
▲
5d:
+4.35%
30d:
+0.7%
90d:
+48.47%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 21, 2026
11d
Get Alerted When COCP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: COCP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: COCP shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: COCP is currently trading at $1.44, which is considered fair relative to its 30-day fair value range of $1.28 to $1.53.
Technical Outlook: Technically, COCP is in a strong uptrend. The price is approaching resistance at $1.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+455.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COCP is in a strong uptrend. The price is approaching resistance at $1.48. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+455.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.28 -
$1.53
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 455.6% below Wall St target ($8.00)
Trading Range Analysis
30-Day Trading Range
$1.28 -
$1.53
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.48
Current Trend
Strong Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.25
Wall Street Target
$8.00
(+455.6%)
Revenue Growth (YoY)
26.9%
Share & Embed Analysis
Last updated: May 09, 2026 11:57 AM ET
Data refreshes hourly during market hours. Next update: 12:57 PM
Data refreshes hourly during market hours. Next update: 12:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COCP showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Phillip Md Et Al Frost
BUY
50000 shares
2026-02-06
Phillip Md Et Al Frost
BUY
50000 shares
2025-12-31
Phillip Md Et Al Frost
BUY
20000 shares
2025-12-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 61 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 58 HOLD |
